We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > MonkeyPox

News List

Monkeypox Case Confirmed in U.S. Resident, Threat of Spread Is Low drugs
July 20, 2021
A case of monkeypox has been confirmed in an American who had recently traveled to Nigeria, U.S. health officials reported. Officials believe the threat of the virus spreading to others is low.
FDA approves vaccine for smallpox and monkeypox europeanpharmaceuticalreview
September 26, 2019
The US Food and Drug Administration (FDA) has announced the approval of Jynneos, a smallpox and monkeypox vaccine for patients 18 years of age or older at high risk of the condition.
FDA Approves Jynneos (Smallpox and Monkeypox Vaccine, Live, Non-replicating) for Prevention of Smallpox and Monkeypox Disease in Adults drugs
September 25, 2019
Bavarian Nordic A/S announced that the U.S. Food and Drug Administration (FDA) has approved Jynneos™ (Smallpox and Monkeypox Vaccine, Live, Non-replicating) (MVA-BN®, liquid-frozen) for prevention ...
MOH confirms imported case of MonkeyPox in Singapore biospectrumasia
May 12, 2019
Risk of transmission from human-to-human is low; MOH’s investigation and tracing operations are in progress in association with NCID